Careers
|
Partnerships
|
Contact
|
Login
Response Biomedical logo
INFLUENZA

RAMP FLU A+B TEST

The RAMP Flu A+B test makes it easy to detect both Flu A and Flu B in nasal samples like swabs and washes. Ideal for diagnosing flu in symptomatic patients, it delivers quick and reliable results to support clinicians in making accurate influenza diagnoses.

The Challenge

Conventional microbiology testing is slow and time-consuming
Demand
The World Health Organization (WHO) estimates that annual influenza (“flu”) epidemics result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths
limitation
Traditional viral culture techniques can take up to 48-72 hours, which can lead to delays in diagnosis and treatment
Subjective Results
Rapid visual tests can be subjective, and their reliability depends on the conditions under which they are used

The Solution

RAMP Flu A+B Test

  • Differentiates between influenza A and B
  • Sample Medium: nasal wash/aspirate, nasopharyngeal aspirate and nasopharyngeal swab
  • Fluorescence immunoassay (FIA) with anti-influenza A and anti-influenza B antibodies bind to influenza A or B nucleoprotein antigens, respectively (if present in the sample)
  • Proprietary RAMP buffer enhances performance
  • A calibrated transfer device is provided with every kit
  • For use with the RAMP 200 only
Accuracy
RAMP Flu A + B tests aid in the rapid differential diagnosis of influenza viral infections in symptomatic patients
Rapid Result
RAMP Flu A + B tests provide objective, qualitative results in ~15 minutes allowing clinicians to administer prompt treatment
High Throughput
The RAMP 200 features a modular and expandable design, enabling clinicians to perform up to 24 assays per hour on a single instrument

Resources

Publications, Webinars and Poster presentations

Contact Our Specialists

24 hour Technical Support available to all RAMP Customers

Faster

Improves turnaround time
for faster triage

Accurate

Provides high quality results
with built in QC

Reliable

Enables clinicians to make
informed decisions
©2025 Response Biomedical. All Rights reserved

You will be able to participate in this research study if you are:

  • 18 years of age or older.
  • In good health.
  • Willing to voluntarily agree to sign the consent form.

You will not be able to participate in this research study if:

  • You are considered/consider yourself to be a vulnerable subject (e.g., nursing home residents, institutionalized persons, pregnant and nursing women, children under the age of 19, prisoners, or persons with decisional incapacity).
  • You are currently diagnosed with, or have a history of, underlying major medical conditions (for example: heart disease, hypertension, stroke, renal disease, diabetes and bleeding disorders).
  • You are actively in hemodialysis treatment.
  • You have been told that you have HIV, chronic active hepatitis B, or chronic, active hepatitis C.
  • You have been hospitalized (for more than 24 hours) in the past three months.
  • You are actively receiving treatment or monitoring for certain cancers (excluding non-melanoma skin cancers and localized prostate cancer not requiring systemic therapy).
  • You are already enrolled in this study.
  • You are unable and/or unwilling to provide informed consent.
If you are interested in participating in this study, you can schedule a time to virtually meet with the clinical team at Response Biomedical. During your online meeting, Response Biomedical will send you a self-assessment questionnaire via DocuSign to determine eligibility. If you are eligbile to participate, a team member will explain the study in detail, review the consent form with you, and send the consent form to you for electronic signature. Once you have signed the consent form, the study staff will arrange an appointment for you at a nearby LifeLabs location.

To participate in this study at a LifeLabs location, you will need to be able to print a paper copy of the requisition to take with you to your appointment. If you do not have access to a printer but would still like to participate, you can book an appointment at the Response Biomedical location or attend a community collection event.
At your LifeLabs appointment, a trained LifeLabs professional will collect two (2) 4 mL tubes of whole blood—approximately two teaspoons.
After collection, your blood sample will be sent to Response Biomedical, where a trained operator will use it to perform the RAMP® hs-TnI test.

Book A Demo

"*" indicates required fields

Name*

Meet Us at the Event

"*" indicates required fields

Name*

Technical Support

"*" indicates required fields

Name*

Get A Quote

"*" indicates required fields

Name*

Partnership

"*" indicates required fields

Name*

You will be able to participate in this research study if you are:

  • 18 years of age or older.
  • In good health.
  • Willing to voluntarily agree to sign the consent form.

You will not be able to participate in this research study if:

  • You are considered/consider yourself to be a vulnerable subject (e.g., nursing home residents, institutionalized persons, pregnant and nursing women, children under the age of 19, prisoners, or persons with decisional incapacity).
  • You are currently diagnosed with, or have a history of, underlying major medical conditions (for example: heart disease, hypertension, stroke, renal disease, diabetes and bleeding disorders).
  • You are actively in hemodialysis treatment.
  • You have been told that you have HIV, chronic active hepatitis B, or chronic, active hepatitis C.
  • You have been hospitalized (for more than 24 hours) in the past three months.
  • You are actively receiving treatment or monitoring for certain cancers (excluding non-melanoma skin cancers and localized prostate cancer not requiring systemic therapy).
  • You are already enrolled in this study.
  • You are unable and/or unwilling to provide informed consent.
If you agree to take part in this study, study staff will discuss a consent form with you. After you sign the consent form, a phlebotomist will collect a blood sample from you. This will include two (2) 4mL tubes worth of whole blood, which is slightly less than 2 teaspoons. Once the blood has been collected, a trained operator will use your blood sample to perform the RAMP® hs-TnI test. The entire visit should last around 30 minutes.